February 6 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] has filed for a regulatory approval to acquire Sofia-based diversified group Doverie United Holding [BUL:5DOV], the country's competition regulator said on Monday.
Sopharma says in its request that the acquisition is not expected to influence any of the sectors the country's economy, the Commission for Protection of Competition said in a statement.
You can subscribe to our M&A newsletter here
In December, Doverie United Holding said that Sopharma had increased its share in the holding group to over 25%.
According to Doverie United Holding's fourth-quarter financial statement Sopharma owned 30.22% of the company equal to 5.67 million shares as of December 31, 2016.
Doverie United Holding spans 20 companies operating in six industrial branches and located in 15 cities in Bulgaria and elsewhere in Europe.
Sopharma operates in the research, development, production, and trade of drugs, vaccines, infusion solutions, medical disposable products, and food supplements primarily in Europe and Bulgaria.
Doverie United Holding shares were trading 1.36% higher at 1.120 levs by 10:25 CET on Monday on the Bulgarian Stock Exchange as 2,100 shares changed hands.
Sopharma shares were not trading as of 10:25 CET on Monday.